pages:
-
A Multi-Center Prospective Cohort Study of Sacral Fractures using Patient Based and Objective Outcomes
-
A Multi-Center Study of a New Method of Sweat Testing: The CF Quantum Sweat Test
-
A Multi-Center Trial to Evaluate Home Based Assessment Methods for Alzheimer's Disease Prevention Research in People Over 75 Years Old (ADC-030-HBA)
-
A Multi-Center Trial to Evaluate Home Based Assessment Methods for Alzheimer's Disease Prevention Research in People Over 75 Years Old (ADC-030-HBA)
-
A Multi-Center, Double-Blind, Randomized Study Comparing the Combined Use of Interferon Beta-1a and Glaltiramer Acetate to Either Agent Alone in Patients with Relapsing Remitting multiple Sclerosis (CombiRx-PhaseIII)
-
A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of Weight-Reduction Diet Plus Acetazolamide vs. Diet Plus Placebo in Subjects with Idiopathic Intracranial Hypertension with Mild Vision Loss
-
A Multi-Center, Randomized, Controlled Trial of Cerebrospinal Fluid Drainage in Acute Spinal Cord Injury
-
A Multi-Center, Randomized, Double-Blind, Phase III Trial Evaluating Corticosteroids with Mycophenolate Mofetil vs. Corticosteroids with Placebo as Initial Systemic Treatment of Acute GVHD
-
A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Trial of the FLT3 Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients with FLT3/ITD AML
-
A Multi-Centered, Randomized, Open-Label, Comparative Study to Assess the Safety and Efficacy of a Treatment Algorithm to Reduce the Use of Vancomycin in Patients with Intravenous Catheter-Associated Blood Stream Infections due to Staphylococci
-
A Multi-Component Behavioral Nutrition Intervention for Homebound Elderly
-
A Multi-Modal Neuro-Physiological Investigation of User-Centered Security
-
A Multi-Site, Double-Blind, Randomized, Placebo-Controlled, Crossover Study of Pregabalin (Lyrica, PGB) in the Treatment of Essential Tremor
-
A Multicenter Group to Study Acute Liver Failure
-
A Multicenter Phase III Randomized Trial Comparing Docetaxel in Combination with Doxorubicin and Cyclophosphamide (TAC) Versus Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC--T) as Adjuvant Treatment of Operable Breast Cancer HER2Neu Negative Patients with Positive Axillary Lymph Nodes
-
A Multicenter Phase III Randomized Trial Comparing Docetaxel in Combination with Doxorubicin and Cyclophosphamide (TAC) Versus Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC--T) as Adjuvant Treatment of Operable Breast Cancer HER2Neu Negative Patients with Positive Axillary Lymph Nodes
-
A Multicenter Phase III Randomized Trial of Adjuvant Therapy for Patients with HER2-Positive Node-Positive or High Risk Node-Negative Breast Cancer Comparing Chemotherapy Plus Trastuzumab with Chemotherapy Plus Trastuzumab Plus Bevacizumab
-
A Multicenter Prospective Cohort Study of Sacral Fractures Using Patient Based and Objective Outcomes
-
A Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units (CBUs) Manufactured by the National Cord Blood Program (NCBP) and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients
-
A Multicenter, Open-Label, Noncomparative Study for the International Maternal, Pediatric, Adolescent AIDS Clinical Trials Group to Evaluate the Safety, Pharmacokinetics, and Antiretroviral Activity of MK-0518 in HIV-1 Infected Children (Study)
-
A Multicenter, Single-Arm, Study Evaluating De Novo Once Every Two Week Darbepoetin alfa Dosing in Pediatric Subjects with Kidney Disease Receiving and Not Receiving Dialysis
-
A Multiplex Label-Free Chip for Pneumococcus Serology
-
A National Consortium to Explore the Genotypic Basis for ESRD in Lupus
-
A Naturalistic Driving Study Across the Lifespan
-
A Naturalistic Driving Study Across the Lifespan
-
A New Approach for Treating Rett Syndrome: Restoration of Interneuron Function by BDNF
-
A New Paradigm: Using PARP Inhibitors to Treat HER2+ Breast Cancer
-
A New Pathway for Neutrophil-Induced Airway Inflammation
-
A NextSeq500 for Heflin Genomics Core
-
A Non-Human Primate Model for Cytomegalovirus Vaccines
pages:
